Emery-Dreifuss muscular dystrophy is a rare form of muscular dystrophy associated with cardiac implications such as cardiomyopathy and arrhythmias leading to sudden death. We describe the anesthetic management of a patient with Emery-Dreifuss muscular dystrophy who presented for orthopaedic surgery and discuss the disorder and its potential anaesthetic implications.
Emery-Dreifuss muscular dystrophy (EDMD) is the third most common of the X-linked recessive muscular dystrophies. It is characterized by early contractures, muscle weakness in a humeroperoneal distribution and cardiomyopathy 1 . These features tend to develop independently of each other 2 . There are only two case reports 5, 7 in the anaesthesia literature. The true frequency of EDMD is unknown 3 , being less common than Becker muscular dystrophy (BMD), which has an incidence of 1 in 33,000 male births 4 .
EDMD was once considered to be a benign muscular dystrophy because the muscular problems are not life-threatening. However it has been recently recognized that the associated cardiac problems present a risk to the patient's life unless a pacemaker is inserted 1, 2, 5, 6 .
CASE HISTORY
A 15-year-old boy diagnosed as having EDMD presented for lengthening of the Achilles tendon on both sides. He had been admitted to a paediatric ward four months previously with eight years history of increasing symmetrical proximal weakness of his legs leading to a gradual tendency to toe walking which the patient had exhibited for four years. He was unable to dorsiflex his ankles with history of recurrent falls when trying to walk quickly, difficulty in getting up from a squatting position and inability to straighten both his elbows. There was no history of any cramps, respiratory problems, chest pain, dysponea, orthopnoea or syncope. A sibling of this patient also suffered from a similar disease.
On general examination the patient was of normal mental state and of average height and weight. His airway was Mallampati Class 2, with normal neck movements. He had bilateral ankle and elbow contractures, lumbar lordosis, and wasting of both arms. There was no calf hypertrophy, wasting of thigh muscle or facial myopathy. His pulse rate was 52/min with blood pressure of 120/78 mmHg. A 24 hour ambulatory ECG showed evidence of paroxysmal atrial flutter with sick sinus syndrome. Lung function tests were within normal limits. Echocardiogram was normal except for mild right atrial and ventricular enlargement. Investigations showed elevation of the plasma creatine phosphokinase (CPK) 627 units/litre (normal range 0-70 U/l) and slightly raised lactate dehydrogenase (LDH) 299 units/litre (normal range 120-240 U/l). All other blood tests (Hb, total leucocyte count, differential leucocyte count, blood sugar, blood urea, liver function tests, and platelet counts) were within normal limits. EMG confirmed signs of long-standing muscle dystrophy with evidence of chronic regeneration. Muscle biopsy performed by a neurologist under local anaesthesia confirmed the diagnosis of EDMD.
At the preoperative visit, the history and findings were confirmed and absence of previous exposure to anaesthesia and any other systemic disease established. After consideration of risks associated with general anaesthesia in the presence of muscular dystrophy and association of sick sinus syndrome, detailed discussion with the patient's parents, surgeon and physician was conducted. It was decided to proceed with temporary pacemaker insertion and graded epidural block.
The night before surgery a temporary transvenous pacemaker was inserted. It was set in demand mode with threshold kept at 7 volts with pacing rate at 50/min. Heparin 5000 U subcutaneous was administered the night prior to surgery as advised by a cardiologist. The patient was premedicated with oral diazepam 5 mg at bedtime the evening before and at 6.30 a.m. on the day of surgery. As he was on heparin, activated partial thromboplastin time (APTT) was performed on the day of surgery. This was 106 s (normal 109-137 s). All mandatory monitoring including ECG (lead II, aVl, V5), non-invasive blood pressure, SpO 2 and temperature (nasopharyngeal) were connected to the patient. The ECG showed normal sinus rhythm with a heart rate of 54 beats/min. The patient was pre-loaded with 500 ml Ringer lactate before administration of an epidural block.
Under full aseptic precautions an 18 gauge epidural catheter was inserted via third and fourth lumbar intervertebral space through a 16 gauge epidural needle by a paramedian approach in the left lateral position. A test dose of 3 ml 2% lignocaine (60 mg) with adrenaline (1:200,000) was given. This was negative. Further graded epidural anaesthesia was administered with 5 ml local anaesthetic increment every five minutes after checking level of block and vital signs. Total 10 ml of 0.5% bupivacaine and 10 ml of lignocaine 2% with adrenaline (1:200,000) was administered over a period of 20 minutes. Sensory block up to T8 level was achieved. This was not associated with any hypotension or rhythm disturbances. Bilateral arterial tourniquets were applied at mid thigh level after exsanguination of the lower limbs by using Esmarch bandages. Mild sedation was provided with midazolam 1 mg IV. The patient's position was supine. Intraoperatively oxygen (FiO 2 0.4) was administered by a Ventimask.
The operation lasted for 60 minutes. Vital signs (blood pressure, heart rate, temperature, SpO 2 ) remained stable through out the operative procedure. The patient did not require vasopressor therapy during the operation. At the end of surgery, the patient was transferred to the post anaesthetic care unit (PACU), where he was monitored until complete regression of block which took two hours. He was then transferred to the ward where the pacemaker lead was removed on the next day by his cardiologists. He had no arrhythmia intraoperatively or in the immediate postoperative period and had no syncopal attack. He was discharged two days after operation for follow-up in the pacemaker clinic regarding possible permanent pacemaker insertion.
DISCUSSION
The muscular dystrophies are a heterogeneous group of inherited myopathies. Clinical and genetic analysis allows classification into four general forms of the disease. In decreasing order of prevalence, these comprise Duchenne dystrophy, myotonic dystrophy, limb-girdle dystrophy and facioscapulohumoral dystrophy 7 . Dreifuss and Hogan in 1961 reported a rare variant of Duchenne muscular dystrophy. In 1966 Emery and Dreifuss defined the unique features that made it distinct from the Duchenne and Becker forms of the disorder (Table 1 ). This variant, in retrospect, may well have been described in two affected brothers as long ago as 1902 5 .
Contractures and cardiac involvement are hallmarks of EDMD, which links to chromosome xq, 28 as a recessively inherited muscular dystrophy. EDMD is a degenerative myopathy presenting in childhood with muscle atrophy and weakness, elbow flexion deformities, forearm weakness and pectus excavatum. This form of muscular dystrophy does not 373 have hypertrophy of muscle. Type 2 muscle fibres are particularly affected. Muscle weakness is noted initially in a humeroperoneal distribution. Later weakness of hip and knee extensors and the proximal upper limb musculature also develops with a tendency for toe-walking by the age of four to five years. This progresses to a waddling gait with lumbar lordosis, but the patient usually remains ambulatory 8 . The severity of heart disease does not correlate with the degree of skeletal muscle involvement. Atrial conduction defects with a bradycardia are considered to be the hallmark of EDMD cardiomyopathy. In asymptomatic patients, an ECG may show low amplitude P waves and a first-degree heart block. Then changes may progress to atrial fibrillation or flutter and then to second degree heart block with a slow junctional rhythm or third degree heart block. Atrial standstill is a pathognomonic finding 9 . A ventricular cardiomyopathy may develop later in the course of the disease. The rate of progression and severity of the cardiac disease is extremely variable. Male hemizygotes and female heterozygotes have been reported with atrial arrhythmias often (in female even without manifesting muscular weakness or contractures) resulting in sudden death unless a pacemaker is inserted or death due to congestive heart failure or complication of thromboemboli from the heart 10 .
CASE REPORT
It should be stressed that the cardiac involvement progresses with age and full assessment with 24-hour ambulatory ECG is essential before sufferers are subjected to any form of anaesthesia.
The diagnosis of EDMD is confirmed by laboratory investigation including muscle biopsy and histology, electromyography, serum enzymes and genetic testing.
EMG examination of the affected muscle demonstrates typical myopathic features of low amplitude and short duration potentials 3 , elevated serum CPK enzymes occur in the serum of males affected with EDMD, as evidence of chronic rhabdomyolysis 9 . The CPK peaks at approximately five times normal in childhood or adolescence and then declines slowly throughout adult life 11 . The aldolase level may be normal in EDMD. Such a disparity between the two muscle enzyme values is not typical of neuromuscular disease 3, 11 . Table 1 shows the distinguishing features between DMD and EDMD, both are X-linked muscular dystrophies.
In the review by Smith 13 there was no mention that a pacemaker may be useful for the management of the patient with DMD. This is in contrast to management of EDMD.
There is bradycardia and prolonged P-R interval in ECG of the patient with EDMD but in DMD, there is tachycardia and a shortened P-R interval. A cardiomyopathy localized to the posterobasal segment of the left ventricle is usual in DMD. In EDMD the patient may have generalized cardiomyopathy, with the atria showing earlier and more severe involvement.
In this case, although the patient was a young male without any overt cardiac symptoms, he had typical elbow contractures along with humeroperoneal weakness and toe-walking. Serum CPK was elevated with slightly raised LDH and EMG showed longstanding muscle dystrophy with chronic regeneration. Muscle biopsy confirmed the diagnosis. Twenty-four hour ECG showed presence of paroxysmal atrial flutter with sick sinus syndrome. After studying the literature it was decided to administer regional anaesthesia as it should be safer than general anaesthesia, in view of cardiac involvement, difficult intubation, susceptibility to malignant hyperthermia and the possibility of prolonged recovery time after use of non-depolarizing muscle relaxant with general anaesthesia 5 .
CONCLUSION
Careful preoperative assessment of the patient with EDMD is essential, because the cardiac problems may be considerable even if the contracture and muscle weakness are minimal, with consideration of prophylactic cardiac pacing before operation or arrangement for emergency cardiac pacing with adequate monitoring.
Regional or local anaesthesia as compared to general anaesthesia would reduce the incidence of the problems of drug interaction, rhabdomyolysis, and problems associated with difficult airway and malignant hyperthermia.
